Bafucin throat lozenges

Bafucin is a well-known brand of throat lozenges primarily marketed in Scandinavia, used for the relief of sore throats and throat infections thanks to its combination of local anesthetics and antibacterial agents. These lozenges have a long history in the Swedish pharmaceutical market, where they were originally developed to provide dual-action relief.

The product shown in the image is manufactured and distributed by McNeil Sweden AB, located in Solna, Sweden. McNeil has historically been a significant player in the consumer healthcare sector, managing various over-the-counter brands.

Starting in 2023 and solidified into 2024 and beyond, the brand is under the ultimate ownership of Kenvue Inc. Kenvue was formed as a spin-off from Johnson & Johnson’s Consumer Health division, becoming a fully independent public company. While the brand remains deeply rooted in its Swedish origins through local manufacturing and regional availability, its global corporate governance is centered in the United States.